In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

In Vivo explains how current events are shaping the future of Life Sciences.
Our informed, sometimes controversial content is delivered by hard-hitting in-house editors and a global team of expert writers who challenge conventional thinking to cut to the core of today’s most pressing issues.

Stay up to date with the latest in biopharma, medtech, and diagnostics:
  • Dealmaking
  • Business Development
  • R&D
  • Regulatory strategies
  • Reimbursement strategies
  • Financial strategies
“In Vivo‘s analyses are among the very best. In Vivo goes beyond the obvious to dissect the new trends affecting the industry.”
GlaxoSmithKline - Former CEO
Providing expert thought leadership in uncertain times.
In Vivo is the essential industry read that provides pragmatic, evidence-based content for critical strategic decision-making. Detailed coverage of competitors' strategies and opinion forming interviews with industry leaders enables executives to mitigate risk and make decisions with confidence.
  • > Growth
  • > Innovation
  • > Leadership
  • > Market Access
  • > Market Intelligence
Past. Present. Future. In Vivo provides critical understanding of how these dynamics impact the global healthcare industry today - and tomorrow.
Register or sign in here to access the full In Vivo archive
“In Vivo starts each month on the top of my reading stack. I read it to inform a view about what to do, and later to learn whether that view was right or wrong.”
Eli Lily - Former SVP, Corporate Policy and Strategy
More targeted content in less time
In Vivo is published continuously on an interactive website. It allows you to access relevant, curated content easily on one intuitive platform. Quickly access the depth of information you need to make business critical decisions.
  • Create custom email alerts
  • Tailor and target search results specific to your areas of interest
  • Easily collect and share content
  • Automatically access related articles, deals, companies and regions
“Those of us who observe the healthcare industry have many sources for data, but few for insightful information and interpretation. In Vivo is a required source for information which is of fundament utility and analytical value.”
Lehman Brothers - Vice Chairman
Access In Vivo Anywhere
User-friendly and fully mobile responsive, you can read and benefit from In Vivo, wherever you need to be. Content available on mobile, PC and tablet.
Lost your password? Click here to update it.
Ask The Analyst
Ask the Analyst puts you in direct contact with our team of experts who are on hand to provide additional guidance and bespoke support for issues and questions that are specific to your business.
Reach out to an analyst now to experience In Vivo’s expert perspective.
Subscribe Today
The C-suite commercial advantage
Decision makers and strategic thinkers in the top 100 pharma and medtech companies rely on In Vivo to outsmart the competition and anticipate future developments.
With our industry shaping content you can:
  • Access commercial strategies
  • Increase market penetration
  • Discover how established products contribute to sales and growth
  • Ensure a balanced portfolio
  • Secure your strategic assets
  • Grow revenues and profitability
  • Track people moves with current executive-level company changes and promotions
  • Tap into incisive projections of industry trends and their implications for your business
  • Focus your partnering and M&A planning with rich deals data from around the world
  • Acquire detailed coverage of your competitors’ strategies
Sign in to your account today Subscribe Today
“In Vivo stands out for its ability to do quality, in-depth analyses of the most important and topical issues facing health care companies. The journal is one of my top sources for staying abreast of what’s happening in the industry.”
Clarus Ventures - Managing Partner
Most Popular Articles
Read our latest thought leadership on pricing and reimbursement here.
Market incumbency isn’t so easy to attain anymore, no matter how much you spend. What can you do to counteract the effects of shrinking market values? We examine this trend:
Find Out More
In a payer-dominated marketplace, targeted market segmentation strategies are vital, and success takes more effort than ever before. Praluent and Repatha could have had better success. Here's how:
Find Out More